Vista Pharmaceuticals P/B Ratio

Current P/B Ratio
0.95
Low Valuation
Low - Trading below book value, may indicate undervaluation

Vista Pharmaceuticals (VISTAPH) P/B ratio is 0.95 (Low), book value per share ₹30.00 vs Healthcare average P/B of -0.01 — Low - Trading below book value, may indicate undervaluation. Explore VISTAPH intrinsic value to estimate fundamental worth using multiple valuation models.

Current Valuation Metrics

P/B Ratio 0.95
Current Price ₹5.88
Book Value/Share ₹30.00
Exchange BSE

Book Value Breakdown (2026)

Balance Sheet Components
Total Equity ₹36 Cr
Share Capital ₹12 Cr
Reserves & Surplus ₹24 Cr
Outstanding Shares 12,000,000
Book Value per Share ₹30.00

Valuation Signal

Signal Undervalued
Historical Avg 0.25
Historical Range 0.2 - 0.32
Percentile 100.0%

Sector Context

Sector Average -0.01
Sector Median 0.62
Sector Rank #11 of 50
Sector Percentile 22.0%

VISTAPH P/B Ratio — Valuation Insights & Book Value Analysis

Vista Pharmaceuticals price-to-book ratio interpretation, valuation status and historical context — current P/B 0.95 (Low). Read Vista Pharmaceuticals dividend policy for the complete payout history and dividend yield track record.

  • Stock appears undervalued with PB of 0.95, trading below book value
  • Trading below book value - potential value opportunity or financial distress signal
  • Current PB is 286.2% above historical average
  • Trading at premium to sector average PB of -0.01

Vista Pharmaceuticals P/B Ratio Historical Trend

VISTAPH annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. For live price, earnings yield and the full fundamental profile, see Vista Pharmaceuticals share price chart.

VISTAPH Historical P/B Ratio — Book Value Per Share & Year-End Price

Vista Pharmaceuticals annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.

Year P/B Ratio Book Value/Share (₹) Year-end Price (₹) Total Equity (₹ Cr) Valuation
2026 0.2 ₹30.0 ₹5.88 ₹36 Low
2025 0.22 ₹37.5 ₹8.14 ₹45 Low
2024 0.26 ₹45.56 ₹11.78 ₹41 Low
2023 0.32 ₹46.25 ₹14.67 ₹37 Low
2022 0.23 ₹51.43 ₹11.78 ₹36 Low

VISTAPH vs Healthcare Peers — P/B Ratio Comparison

Vista Pharmaceuticals P/B 0.95 vs Healthcare average -0.01, median 0.62 — range -6.55–1.09.

Sector Average
-0.01
Sector Median
0.62
Lowest P/B
-6.55
Highest P/B
1.09
Companies
50
Company Symbol P/B Ratio Market Cap (₹ Cr) Valuation
Parmax Pharma PARMAX -6.55 ₹46 Low
Span Divergent SDL -6.32 ₹19 Low
Oxygenta Pharmaceutical OXYGENTAPH -5.54 ₹203 Low
Satiate Agri SATAGRI -3.39 ₹8 Low
Adline Chem Lab ADLINE -3.03 ₹5 Low
Bharat Immunologicals BIBCL -2.0 ₹65 Low
Krebs Biochemicals & Ind… KREBSBIO -0.82 ₹129 Low
Cresanto Global CRESANTO -0.7 ₹2 Low
Vivimed Labs VIVIMEDLAB -0.21 ₹50 Low
Triochem Products TRIPR 0.04 ₹0 Low